Trademarkia Logo

Australia

AU$
QINPREZO
Ceased - Not renewed: Renewal fee not paid

Last updated on 17 Aug 2023

Owner Info

Sunesis Pharmaceuticals, Inc.

Suite 400

395 Oyster Point Blvd, UNITED STATES OF AMERICA

Serial Number

1548772 filed on 23 Jan 2013

Correspondent

Harold Milstein Sheppard Mullin Richter & Hampton LLP

379 Lytton Avenue,

Palo Alto CA 94301,

UNITED STATES OF AMERICA

QINPREZO

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of tumors, cancers, hematological disorders and hematological malignancies

Mark Details


Serial Number

1548772

Registered On

23 Jan 2013

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

2 Aug 2012

Mark Type

US

Legal History


Show more

Status DateAction Taken
17th Aug 2023Status change to Removed/Ceased - Not Renewed
25th Jul 2013IP Right Registration Published
19th Jul 2013Register Trade Mark
19th Jul 2013Application Status
11th Apr 2013IP Right Acceptance Published
4th Apr 2013IP Right Filed Published
3rd Apr 2013Clear Examination report approved
3rd Apr 2013Application Accepted correspondence sent
28th Mar 2013Application Status
28th Mar 2013Application Status